(Q34324240)

English

Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial (English)

1 reference

Europe PubMed Central

1 August 2017

multicenter clinical trial

0 references

nephrotic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Takao Saito

1

1 reference

Europe PubMed Central

1 August 2017

Masayuki Iwano

2

1 reference

Europe PubMed Central

1 August 2017

Koichi Matsumoto

3

1 reference

Europe PubMed Central

1 August 2017

Tetsuya Mitarai

4

1 reference

Europe PubMed Central

1 August 2017

Hitoshi Yokoyama

5

1 reference

Europe PubMed Central

1 August 2017

Noriaki Yorioka

6

1 reference

Europe PubMed Central

1 August 2017

Shinichi Nishi

7

1 reference

Europe PubMed Central

1 August 2017

Ashio Yoshimura

8

1 reference

Europe PubMed Central

1 August 2017

Hiroshi Sato

9

1 reference

Europe PubMed Central

1 August 2017

Satoru Ogahara

10

1 reference

Europe PubMed Central

1 August 2017

Hideki Shuto

11

1 reference

Europe PubMed Central

1 August 2017

Yasufumi Kataoka

12

1 reference

Europe PubMed Central

1 August 2017

Shiro Ueda

13

1 reference

Europe PubMed Central

1 August 2017

Akio Koyama

14

1 reference

Europe PubMed Central

1 August 2017

Shoichi Maruyama

15

1 reference

Europe PubMed Central

1 August 2017

Masaomi Nangaku

16

1 reference

Europe PubMed Central

1 August 2017

Enyu Imai

17

1 reference

Europe PubMed Central

1 August 2017

Seiichi Matsuo

18

1 reference

Europe PubMed Central

1 August 2017

Yasuhiko Tomino

19

1 reference

Europe PubMed Central

1 August 2017

Refractory Nephrotic Syndrome Study Group

20

1 reference

Europe PubMed Central

1 August 2017

publication date

23 December 2013

1 reference

Europe PubMed Central

1 August 2017

Clinical and experimental nephrology

1 reference

Europe PubMed Central

1 August 2017

18

1 reference

Europe PubMed Central

1 August 2017

5

1 reference

Europe PubMed Central

1 August 2017

784-794

1 reference

Europe PubMed Central

1 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

23 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s10157-013-0925-2

0 references

Optimal C2 concentration of cyclosporin corrected with good efficacy and safety in Asian kidney transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Direct effects of dexamethasone on human podocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Patient management by Neoral C(2) monitoring: an international consensus statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Clinical validation studies of Neoral C(2) monitoring: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

NFAT signaling: choreographing the social lives of cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

The effect of food and bile acid administration on the relative bioavailability of cyclosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194018

6 July 2018

A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0925-2

21 January 2018

Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0925-2

21 January 2018

Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0925-2

21 January 2018

Outcome of microemulsion cyclosporine C2 concentration monitoring in kidney transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0925-2

21 January 2018

Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0925-2

21 January 2018

Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring

1 reference

https://api.crossref.org/works/10.1007%2FS10157-013-0925-2

21 January 2018

Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines for the treatment of nephrotic syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C2

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24363128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10157-013-0925-2

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34324240&oldid=1863185522"